Concepedia

Michael K. Badman

MK

Statistics

Publications

23

Citations

5.3K

H-Index

21

Active since

1996

Affiliations

Beth Israel Deaconess Medical Center(Current)

Novartis (United States)

Harvard University

Novartis (Switzerland)

Novartis Institutes for BioMedical Research

Michael K. Badman is an author at Beth Israel Deaconess Medical Center specializing in medicine, liver disease, and pharmacology.

Publications per year

1996–2023

23

Publications

23

Hepatic Fibroblast Growth Factor 21 Is Regulated by PPARα and Is a Key Mediator of Hepatic Lipid Metabolism in Ketotic States

Michael K. Badman, Pavlos Pissios, Adam R. Kennedy et al. · Cell Metabolism · 2007 · 1.5K citations · Full text

, , +15

Kisspeptin-54 Stimulates the Hypothalamic-Pituitary Gonadal Axis in Human Males

Waljit S. Dhillo, Owais B. Chaudhri, Michael Patterson et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 651 citations · Full text

, , +14

Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease

Jody Dushay, Patricia C. Chui, Gosala Gopalakrishnan et al. · Gastroenterology · 2010 · 595 citations · Full text

, , +14

Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid Metabolism

Mary‐Elizabeth Patti, Sander M. Houten, Antônio C. Bianco et al. · Obesity · 2009 · 591 citations · Full text

, , +17

Fibroblast Growth Factor 21-Deficient Mice Demonstrate Impaired Adaptation to Ketosis

Michael K. Badman, Anja Köester, Jeffrey S. Flier et al. · Endocrinology · 2009 · 354 citations · Full text

, , +17

1–5 of 23